Parteck® M 200 (Mannitol) EMPROVE ESSENTIAL Ph Eur,BP,JP,USP,E 421

Description

Parteck® M 200 excipient is part of the Parteck® range of functional excipients developed specifically for solid oral dose applications. It is a directly compressible mannitol with excellent compressibility which keeps the API stable and enables rapid disintegration and fast dissolution. As Emprove® Essential excipient, it is a high quality pharmaceutical excipient, offered with extensive documentation facilitating compliance, full supply chain transparency and risk mitigation.

The directly compressible mannitol Parteck® M is a good choice for rapid release of high-dose or low-dose active pharmaceutical ingredients (APIs). Developed under Merck’s advanced Functional Particle Engineering concept, it is available in two different particle size distributions: Parteck® M 100 and Parteck® M 200.

Benefits of Parteck® M:

• High compactibility at low compression forces
• Rapid disintegration and fast dissolution
• High dilution potential
• Non-hygroscopic, exceptionally low content of reducing sugars
• Emprove® documentation and regulatory support

Unique Particle Structure

With its unique particle structure, Parteck® M mannitol allows you to press robust, high-quality tablets with direct compression – no need for prior granulation steps. It is also suitable for low-dose formulation where dose uniformity and mix homogeneity are crucial.